One health
Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.
News
Protecting infants against respiratory syncytial virus this winter — ECDC issues advice
ECDC has issued rapid scientific advice for policymakers and public health authorities on ways to mitigate the impact of RSV disease among infants through immunisation and to support intensified efforts to protect them from RSV across Europe.
Read story
NewsBiomedical Sciences researcher receives nearly $7 million in federal grants to fight STIs
Cynthia Nau Cornelissen, a Distinguished University Professor and associate director of the Institute for Biomedical Sciences at Georgia State University, has received nearly $7 million in two, five-year federal grants to develop vaccines and therapeutics to combat sexually transmitted infections (STIs).
NewsExperts urge continued hepatitis B vaccine birth doses for newborns
In a new commentary, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth. Hepatitis B vaccines are safe and effective with over one billion doses administered worldwide.
NewsKorea University College of Medicine’s Vaccine Innovation Center selected as lead institution for 2025 Korea-ARPA-H Health Security Project
The Vaccine Innovation Center at Korea University College of Medicine has been selected as the lead institution for a health security research initiative under the Ministry of Health and Welfare’s “2025 Korea-ARPA-H Project.”
More One Health
News
New test could allow for more accurate Lyme disease diagnosis
Researchers have developed a new way to detect the Lyme disease bacterium Borrelia burgdorferi, allowing for faster and more accurate diagnosis.
NewsNew test could speed detection of three serious regional fungal infections
Researchers have developed a new molecular test capable of detecting three major pathogenic fungi at once — and with a much quicker turnaround than traditional methods.
NewsNew DNA analysis approach could transform understanding of disease evolution
By adapting techniques originally used to study ancient DNA from archaeological specimens, researchers were able to recover genetic information from nearly century-old medical samples.
NewsThe link between the gut microbiome and autism is not backed by science, researchers say
There’s no scientific evidence that the gut microbiome causes autism, a group of scientists argue in an opinion paper. They warn that conclusions that supported this hypothesis are undermined by flawed assumptions, small sample sizes, and inappropriate statistical methods.
NewsManganese is Lyme disease bacterium’s double-edged sword
For decades, Lyme disease has frustrated both physicians and patients alike. Caused by the corkscrew-shaped bacterium Borrelia burgdorferi, the infection, if left untreated, can linger for months, leading to fever, fatigue and painful inflammation.
NewsScientists find way to find the gut microbiome into a longevity factory
A team of researchers has found a way to turn the bacteria living in the digestive tracts of animals into factories that can produce compounds that promote longevity in their hosts—showing a potential new drug development strategy.
NewsFirst-in-North-America resource touts research into health benefits of fermented foods
A one-stop network, the first of its kind in North America, has begun sharing easily digested research, recipes and other resources about the health benefits of fermented foods. The new Canadian Fermented Foods Initiative (CFFI) launches officially on Nov. 17.
NewsTyphoid conjugate vaccine demonstrates strong safety and immunogenicity: Results from Phase 3 study
PATH and EuBiologics Co., LTD have announced Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.®
NewsRainfall and temperature shape mosquito fauna in Atlantic Forest bromeliads, including malaria vectors
Results from a study of mosquito larvae conducted in a natural area in the municipality of São Paulo (Brazil) may help estimate the effects of climate change on disease transmission risk in the biome.
CareersSummer studentship: Jonas investigates how metals influence bacterial ecosystems
Jonas Flohr from Portsmouth reports back on his AMI-sponsored summer studentship at Durham University investigating how metals influence bacterial ecosystems.
NewsBacteriophage characterization provides platform for rational design
Researchers have described the bacteriophage Bas63 in unprecedented detail, supporting new mechanistic understanding of how these viruses function.
NewsScientists tie lupus to a virus nearly all of us carry
The Epstein-Barr virus is directly responsible for commandeering what starts out as a minuscule number of immune cells to go rogue and persuade far more of their fellow immune cells to launch a widespread assault on the body’s tissues, a study has shown.
NewsStudy finds high rates of antibiotic-resistant bacteria in raw milk
Raw cow and sheep milk is frequently contaminated with antibiotic-resistant bacteria that could pose a threat to human and animal health, reports a new study.
NewsSingle-dose malaria treatment combining four existing drugs as effective as more onerous multi-day, multi-dose regimen
Hundreds of malaria patients participating in a clinical trial in Gabon in West Africa were cured via a single dose of a treatment that utilizes four widely available malaria drugs, according to a new study.
NewsStudy reveals that flu vaccine performance varies by age
New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age of the patient.
NewsCracking leishmaniasis: new DNA test to track infection
A new study offers an innovative way to track the spread of leishmaniasis, a parasitic disease affecting both animals and humans. Researchers developed a fast, reliable method to identify sand fly species, detect Leishmania parasites, and determine the source of their blood meals from a single sample.
NewsScientists harness algae for a greener way to create functional gold nanoparticles
Researchers have pioneered a novel, sustainable method for synthesizing functionalized gold nanoparticles (AuNPs) using microalgae. This approach not only avoids the harsh chemicals used in conventional methods but also produces AuNPs that are more stable and less toxic to healthy cells.
NewsMissing links for rabies in Peru highlights global threats of health inequity
Researchers found that efforts to track dog-related rabies in poorer areas of Peru’s second largest city were lacking even though more dogs were found to have the disease there than in wealthier neighborhoods.
NewsEgypt becomes the seventh country in the Eastern Mediterranean Region to eliminate trachoma as a public health problem
The World Health Organization (WHO) today announced that Egypt has successfully eliminated trachoma as a public health problem, marking a historic public health milestone for the country and WHO’s Eastern Mediterranean Region (WHO EMR).